Home » Authors » Jennifer Boggs

Jennifer Boggs

Articles

ARTICLES

Genomic Health's IPO Adds $60M For Breast Cancer Test

Sep. 30, 2005

By Jennifer Boggs

Sirna's RNAi Work Lands $250M Deal With Allergan

Sep. 30, 2005

By Jennifer Boggs

Genomic Health's IPO Adds $60M For Breast Cancer Test

Sep. 30, 2005

By Jennifer Boggs

Insmed's Growth Hormone Approvable; 'Issues' Remain

Sep. 29, 2005

By Jennifer Boggs

Scynexis, Merial Enter Potential $150M Animal Health Partnership

Sep. 29, 2005

By Jennifer Boggs

Scynexis, Merial Enter Potential $150M Animal Health Partnership

Sep. 29, 2005

By Jennifer Boggs

Insmed's Growth Hormone Approvable; 'Issues' Remain

Sep. 29, 2005

By Jennifer Boggs

Banking On MyoCell, Bioheart Gets Series D Round Of $19M

Sep. 28, 2005

By Jennifer Boggs

Sunesis Prices $42M IPO To Fuel Oncology Pipeline

Sep. 28, 2005

By Jennifer Boggs

Sunesis Prices $42M IPO To Fuel Oncology Pipeline

Sep. 28, 2005

By Jennifer Boggs

View All Articles by Jennifer Boggs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...